Sheryl K. Elkin

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing

Teresa Helsten, Sheryl K. Elkin, Elisa Arthur et al. · Clinical Cancer Research · 2015 · 786 citations · Full text

<i>RET</i> Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients

Shumei Kato, Vivek Subbiah, Erica Marchlik et al. · Clinical Cancer Research · 2016 · 275 citations

Deletion of the RAG2 C terminus leads to impaired lymphoid development in mice

Yoshiko Akamatsu, R. J. Monroe, Darryll D. Dudley et al. · Proceedings of the National Academy of Sciences · 2003 · 106 citations · Full text

Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation

Russell W. Jenkins, Geoffrey R. Oxnard, Sheryl K. Elkin et al. · Clinical Lung Cancer · 2015 · 97 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +9

Genomic Landscape of Malignant Mesotheliomas

Shumei Kato, Brett N. Tomson, Timon P.H. Buys et al. · Molecular Cancer Therapeutics · 2016 · 86 citations · Full text